NCT06450262View on ClinicalTrials.gov

Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 4, 2024

Primary Completion Date

January 16, 2024

Study Completion Date

March 5, 2024

Conditions
Type2diabetes
Interventions
DRUG

Emapgliflozin/Metformin 12.5mg/1000mg Film-coated tablets

1 tablet of Emapgliflozin/Metformin 12.5mg/1000mg Film-coated tablets

DRUG

Synjardy® 12.5mg/1000mg film-coated tablets

1 tablet of Emapgliflozin/Metformin 12.5mg/1000mg Film-coated tablets

Trial Locations (1)

Unknown

ACDIMA Biocenter, Amman

All Listed Sponsors
lead

Humanis Saglık Anonim Sirketi

INDUSTRY

NCT06450262 - Bioequivalence Study to Compare Empagliflozin/ Metformin HCl 12.5mg/1000mg Film-coated Tablets | Biotech Hunter | Biotech Hunter